Related Experiment Video
Updated: Mar 19, 2026
07:35
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
13.3K
[Multidrug-resistant tuberculosis in children: about two cases]
Hajar Slimani1, Myriem Bricha1, Fatima-Ezzahra Sqalli1
1Service de Pneumo-Phtisiologie, Hôpital Moulay Youssef, CHU Rabat, Akkari, Faculté de Médecine et de Pharmacie de Rabat, 10000, Maroc.
The Pan African Medical Journal
|June 10, 2016
Summary
Multidrug-resistant tuberculosis (MDR-TB) in children is a serious global health issue. This report details two pediatric cases successfully treated with second-line drug regimens for MDR-TB.
Area of Science:
- Pediatric infectious diseases
- Mycobacterial infections
- Global public health
Background:
- Multidrug-resistant tuberculosis (MDR-TB) poses a significant threat, particularly in developing nations.
- Pediatric MDR-TB requires specialized treatment approaches due to limited drug options and unique physiological considerations.
Observation:
- The study presents two pediatric cases of multidrug-resistant tuberculosis.
- Both children were treated under the observation of the reporting team during their training.
Findings:
- Successful treatment outcomes were achieved using second-line drug regimens.
- The cases highlight the feasibility and effectiveness of second-line therapies in pediatric MDR-TB.
Implications:
- These findings underscore the importance of timely diagnosis and appropriate management of pediatric MDR-TB.
- The successful use of second-line regimens offers a viable treatment strategy for children with drug-resistant tuberculosis, contributing to improved global health outcomes.
More Related Videos
Related Concept Videos
01:28Pulmonary Tuberculosis V
745
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
745
01:29Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
01:26Pulmonary Tuberculosis IV
622
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
622
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
360
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
01:28Pulmonary Tuberculosis II
1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
01:31Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K